Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery receives Crédit d’Impôt Recherche accreditation

Sygnature Discovery has received Crédit d’Impôt Recherche (CIR) accreditation from the French Ministère de l’Éducation nationale, de l’Enseignement supérieur et de la Recherche.  This accreditation allows French companies to benefit from significant tax relief on drug discovery research undertaken by Sygnature on their behalf.

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…